Cargando…
Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide with rates of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) dramatically increasing. The overexpression of enhancer of zeste homolog 2 (EZH2), a histone methyltransferase responsible f...
Autores principales: | Lindsay, Cameron D., Kostiuk, Morris A., Harris, Jeff, O’Connell, Daniel A., Seikaly, Hadi, Biron, Vincent L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586065/ https://www.ncbi.nlm.nih.gov/pubmed/28878842 http://dx.doi.org/10.1186/s13148-017-0390-y |
Ejemplares similares
-
Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs
por: Isaac, Andre, et al.
Publicado: (2017) -
Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer
por: Idris, Sherif, et al.
Publicado: (2016) -
Association of human papillomavirus related squamous cell carcinomas of the oropharynx and cervix
por: Gazzaz, Malak Jamal, et al.
Publicado: (2019) -
EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma
por: Sivarajah, Shanmugappiriya, et al.
Publicado: (2019) -
The impact of human papillomavirus (HPV) status on functional outcomes and quality of life (QOL) after surgical treatment of oropharyngeal carcinoma with free-flap reconstruction
por: Marzouki, Hani Z., et al.
Publicado: (2018)